Physician profile
Yi Jia
NPI 1891907515
$1,786.49
in general payments reported to CMS, 2019-2025
15 companies · $32.78 in 2025
The $32.78 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $147 · 2021: $553 · 2022: $300 · 2023: $418 · 2024: $27.01 · 2025: $32.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $558.36 | 2019-2023 | Xarelto |
| Pfizer INC. | $238.79 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $160.45 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.36 | 2020-2023 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $128.41 | 2019-2022 | |
| Abbvie INC. | $125.12 | 2021-2023 | |
| Gilead Sciences, INC. | $109.78 | 2022 | |
| Inari Medical, INC. | $103.25 | 2021-2022 | |
| Ucb, INC. | $67.79 | 2022-2023 | Briviact |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Stryker Corporation | $32.78 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Glaxosmithkline, LLC. | $27.01 | 2024 | Trelegy Ellipta |
| Vifor Pharma, INC. | $24.54 | 2019-2021 | |
| Boston Scientific Corporation | $19.47 | 2022 | |
| Merck Sharp & Dohme LLC | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Jia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.